OPTEASE® Retrievable Vena Cava Filter

An innovative option for prevention of recurrent pulmonary embolism. It offers all the proven strengths of the Cordis TRAPEASE® Permanent Vena Cava Filter plus the additional option of retrieval.
Product Description

OPTEASE® Retrievable Vena Cava Filters offer:

  • Dual-layer filtration for prevention of recurrent pulmonary embolism.
  • Closed cage structure designed to eliminate risk of caval perforation and strut embolizaion.
  • Self-centering side struts reduce the risk of tilting.
  • Fixation barbs minimize migration to maintain clot capture efficiency.
  • Dual Prong Caudal Hook for easire capture with any appropriate endovascular snare. No additional training required.
  • Caval coverage up to 30mm.

The low profile OPTEASE® Retrievable Vena Cava Filter kit provides more options:

  • 90cm kit allows filter delivery through right and left antecubital or jugular veins.
  • Femoral 55cm kit allows filter delivery through through right and left femoral veins.
  • Jugular 55cm kit allows filter delivery through right and left jugular veins.

Cordis VISEASE® Angiographic Vessel Dilator simplifies pre-placement venacavogram

  • Radiopaque markers set 30mm apart for direct, in-vessel IVC sizing.
  • Can simplify inventory management: pigtail catheter no longer needed.
  • Fewer guidewire and catheter exchanges shorten and simplify pre-placement procedure.

Cordis BRITE TIP® Interventional Sheath 6F (8F OD) provides flexibility and support for easy tracking through tortuous vessels

  • Low profile minimizes patient trauma and insertion site thrombosis.
  • Radiolucent cannula allows the filter to be visible as it moves through sheath.
  • Radiopaque tip is highly visible to enable accurate infrarenal placement.
  • 6F obturator with marker band supports a controlled release during filter delivery.
  • SLIX Valve for maximal hemostasis.
Ordering Information
In the United States, email us your order at GMB-CORDIS-CUSTOMER-SUPPORT@cardinalhealth.com or call us at 800.327.7714.
Please refer to the Instructions For Use for complete information, including indications, precautions, warnings, and potential adverse events.